期刊文献+

高效液相色谱法分析胸苷衍生物BOC-FLT含量

Determination of thymidine derivatives BOC-FLT by high performance liquid chromatography
原文传递
导出
摘要 目的:建立一种HPLC法分析正电子发射断层(PET)肿瘤诊断药物^18F-FLT标记前体BOC-FLT的含量,为药盒质量控制提供有效的检测手段。方法:乙腈作为溶剂,235nm作为检测波长,乙腈水(85:15)作流动相,HPLC法分析BOC-FLT含量。结果:主峰保留时间为6.6min,杂质峰保留时间为4.5min,分离度大于1.5,BOC-FLT在100-500mg·L^-1试验范围内呈良好的线性关系,回归方程为y=3E+06x-301953,R^2=0.9995。FLT-BOC最小检出量为2.5ng(S/N≥3);杂质最小检出量为1.2ng(S/N≥3)。结论:方法简便、可靠,重复性好,能够为药盒的质量控制提供有效的分析手段。 OBJECTIVE To establish a simple and rapid method for determining the concentration of BOC -FLT.which is a labeling precursor of ^18F-FLT. METHODS The content of BOC-FLT was determinated by reversed phase HPLC using acetonitrile as solvent.acetonitrile/water 85/15 as mobile phrase and 235 nm as detect wavelength. RESULTS The retention time of the main peak was 6.6 rain,and that of impurity was 4. 5 min. The resolution of FLT- BOC and impurity was 〉 1.5. The cali bration curve was linear in the concentration range of 100 -500mg·L^-1 (y = 3E + 06x- 301 953,R^2 =0. 999 5). Detection Limit of BOC-FLT was 2.5 ng(S/N≥3) ,and that of impurity was 1.2 ng(S/N≥3). CONCLUSION The method can provide effective means to the quality control of the drug with simple and credibility.
出处 《中国医院药学杂志》 CAS CSCD 北大核心 2011年第6期464-466,共3页 Chinese Journal of Hospital Pharmacy
基金 国家自然科学基金项目(编号:30770602) 江苏省自然科学基金项目(编号:BK2008112)
关键词 高效液相色谱 BOC-FLT 含量 high performance liquid chromatography BOC-FLT content
  • 相关文献

参考文献6

二级参考文献71

  • 1王明芳,罗志福.肿瘤增殖显像剂3'-脱氧-3'-^(18)F-氟代胸苷[J].国外医学(放射医学核医学分册),2005,29(5):227-232. 被引量:2
  • 2Been L B, Suurmeijer A J H, Cobben D C P, et al. [^18F] FLT-PET in Oncology: Current Status and Opportunities[J]. Eur J Nucl Med Mol Imag, 2004, 31(12): 1 659-1 672.
  • 3Reske S N, Deisenhofer S. Is 3'-Deoxy-3' 18 F-Fluorothymidine a Better Marker for Tumour Response Than ^18F-Fluorodeoxyglueose?[J]. Eur J Nuel Med Mol Imag, 2006, 33(13): S38-S43.
  • 4Martina S J, Eisenbartha J A, Wagner-Utermanna U, et al. A New Precursor for the Radiosynthesis of [^18F]FLT[J]. Nucl Med Biol, 2002 (29): 263-273.
  • 5Mikyung Yun, Seung Jun Oh, Hyun-Joon Ha, et al. High Radiochemical Yield Synthesis of 3-Deoxy- 3-[^18F]Fluorothymidine Using(5'-O-Dimethoxytrityl-2 '-Deoxy-3 '-O-Nosyl-β-D-Threo Pentofuranosyl) Thymine and Its 3-N-BOC-Proteeted Analogue as a Labeling Precursor[JJ. Nucl Med Biol, 2003 (30) : 151-157.
  • 6Seung J O, Christoph M, Dae Y C, et al. Fully Automated Synthesis System of 3-Deoxy-3-[^18F] Fluorothymidine[J]. Nucl Med Biol, 2004 (31): 803-809.
  • 7Byung S M, Kyo C L, Gwang I A, et al. Preparation of 3 '-Deoxy-3'-[^18F] Fluorothymidine ([^18F]FLT) in Ionic Liquid, [bmim][OTf][J]. J Label Compd Radiopharm, 2006, 49: 287-293.
  • 8Sakamoto S, Iwama T, Tsukada K, et al. Increased activity of thymidine kinase isozyme in human colon tumor. Carcinogenesis, 1984, 5:183-185.
  • 9Nawata H, Kamiya T. Two molecular forms of thymidine kinase in the cytosol of regenerating rat liver. J Biochem, 1975, 78: 1215-1224.
  • 10Munch-Petersen B, Tyrsted G. Induction of thymidine kinase in phytohaemagglutinin-stimulated lymphocytes. Biochem Biophys Acta,1977, 478: 364-375.

共引文献20

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部